(iv) PD-L1 binding to its receptor PD-1 inhibits T cells (40); increased soluble levels in plasma are associated with poor prognosis, shorter survival, and resistance to immunotherapy in different several cancers (41). This evidence concerns the gene CD274 and cancer.